Virios Therapeutics (NASDAQ:VIRI) Trading 0.8% Higher – Here’s What Happened

Virios Therapeutics, Inc. (NASDAQ:VIRI)’s stock price rose 0.8% on Friday . The stock traded as high as $2.60 and last traded at $2.51. Approximately 22,306 shares changed hands during mid-day trading, a decline of 98% from the average daily volume of 1,049,645 shares. The stock had previously closed at $2.49.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright boosted their price target on shares of Virios Therapeutics from $0.20 to $5.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 9th.

Virios Therapeutics Price Performance

The stock has a market cap of $50.26 million, a price-to-earnings ratio of -9.67 and a beta of 1.58. The firm has a fifty day moving average of $3.02 and a 200 day moving average of $1.53.

Virios Therapeutics Company Profile

Virios Therapeutics, Inc, a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia.